Acutus Competitors

Pink Sheets . USA . 
Stock . Acutus Medical
AFIB Stock  USD 0  0.0009  30.00%   
Analyzing Acutus Medical competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Acutus Medical to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Acutus Medical Correlation with its peers.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Acutus Medical competition on your existing holdings.
  
Specify up to 10 symbols:
Hype
Prediction
LowEstimatedHigh
0.00050.20
Details
Intrinsic
Valuation
LowRealHigh
0.00050.20
Details
Naive
Forecast
LowNextHigh
0.0000920251.52
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
-0.0010.00060
Details

Acutus Medical Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Acutus Medical and its competitors represents the degree of relationship between the price movements of corresponding pink sheets. A correlation of about +1.0 implies that the price of Acutus and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Acutus Medical does not affect the price movement of the other competitor.

High positive correlations

CGHC
+ 1.0
TCLIF
SWNM
+ 1.0
TCLIF
WPHM
+ 1.0
TCLIF
SWNM
+ 1.0
CGHC
WPHM
+ 1.0
CGHC
WPHM
+ 1.0
SWNM
  

High negative correlations

EVLO
- 0.0
LFPI
LFPI
- 0.0
ICCT
EVLO
- 0.0
WPHM
LFPI
- 0.0
WPHM
ICCT
- 0.0
WPHM
EVLO
- 0.0
INFIQ

Risk-Adjusted Indicators

There is a big difference between Acutus Pink Sheet performing well and Acutus Medical Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Acutus Medical's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
TCLIF  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
 0.00 
 0.00 
IGNT  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
 0.00 
 0.00 
CGHC  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
 0.00 
 0.00 
ARDS  222.81  112.76  1.33  4.12  39.74 
(614.88)
 1,000.00 
(90.91)
 1,141 
SWNM  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
 0.00 
 0.00 
INFIQ  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
 0.00 
 0.00 
WPHM  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
 0.00 
 0.00 
ICCT  57.43  20.62  0.37  2.12  33.32 
(114.39)
 233.33 
(72.73)
 540.00 
LFPI  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
 0.00 
 0.00 
EVLO  17.00  3.95  0.00  0.49  0.00 
 0.00 
 0.00 
(50.00)
 400.00 
All Fundamental Data

Acutus Medical Competitive Analysis

The better you understand Acutus Medical competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Acutus Medical's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Acutus Medical's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
AFIB TCLIF CGHC ARDS SWNM WPHM ICCT EVLO
 30.00 
 0 
Acutus
 0.00 
 0.0002 
Theraclion
 0.00 
 0.0001 
Cptl
 91.30 
 0.0002 
Aridis
 0.00 
 0.0001 
Southwestern
 0.00 
 0.0003 
Winston
 50.00 
 0 
ICoreConnect
 80.00 
 0.0001 
Evelo
Market Volatility
(90 Days Market Risk)
Out of control
Very steady
Very steady
Out of control
Very steady
Very steady
Out of control
Out of control
Market Performance
(90 Days Performance)
Solid
Weakest
Weakest
Strong
Weakest
Weakest
Solid
Mild
Odds of Financial Distress
(Probability Of Bankruptcy)
Moderate
Low
Small
Average
Low
Low
High
Strong
Current Valuation
(Equity Enterprise Value)
Over Valued
Over Valued
Over Valued
Over Valued
Over Valued
Over Valued
Over Valued
Under Valued
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Sell
Strong Sell
Strong Sell
Cautious Hold
Strong Sell
Strong Sell
Sell
Cautious Hold
Current Ratio
5.11 X
1.86 X
0.52 X
0.41 X
14.00 X
1.04 X
0.35 X
4.53 X
Net Asset
53.96 M
10.83 M
33.79 K
14.7 M
39.4 K
1.68 M
15.69 M
64.44 M
Profit Margin
N/A
N/A
(0.46) %
N/A
N/A
(1.70) %
(2.63) %
N/A
EBITDA
(13.49 M)
(4.44 M)
(1.55 M)
(29.51 M)
N/A
(2.41 M)
(11.88 M)
(108.41 M)
Operating Margin
(2.89) %
(8.41) %
(0.45) %
(9.58) %
N/A
(1.46) %
(0.79) %
N/A
Current Valuation
18.75 M
21.63 M
1.6 M
12.11 M
204.31 K
774.09 K
15.62 M
23.69 M
Price To Book
0.53 X
54.78 X
0.12 X
5.40 X
N/A
12.46 X
8.91 X
3.51 X
Retained Earnings
(599.98 M)
N/A
(13.23 M)
(195.67 M)
(172.24 K)
N/A
(115.04 M)
(529.22 M)
Current Asset
N/A
N/A
1.75 M
27.39 M
N/A
811 K
N/A
49.29 M
Beta
0.26
0.57
0.99
0.78
-110.96
-1383.1
-0.71
1.74
Number Of Employees
230
28
2
37
N/A
9
67
66
Shares Outstanding
29.72 M
28.8 M
92.2 M
36.21 M
82.94 M
77.41 M
2.07 M
18.93 M
Cash Flow From Operations
(63.61 M)
(3.88 M)
(434.59 K)
(29.13 M)
(133.73 K)
(4.2 M)
(8.82 M)
(101.23 M)
Annual Yield
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Debt
38.48 M
2.94 M
N/A
6.13 M
208.69 K
1.19 M
7.88 M
51.14 M
Return On Equity
-0.32
N/A
-0.45
N/A
N/A
-2.05
-17.18
-62.33
Z Score
N/A
13.2
N/A
-26.03
N/A
N/A
N/A
-16.24
Return On Asset
-0.14
-0.25
-0.18
-1.08
N/A
-0.59
-0.7
-0.83
Number Of Shares Shorted
553.6 K
N/A
N/A
2 M
N/A
N/A
351.55 K
430.1 K
Book Value Per Share
(0.03) X
(0.06) X
0.12 X
(0.77) X
(0) X
0 X
(5.11) X
(1.42) X
Current Liabilities
N/A
N/A
3.33 M
3.06 M
N/A
777 K
N/A
4.32 M
Total Asset
53.96 M
10.83 M
33.79 K
14.7 M
39.4 K
1.68 M
15.69 M
64.44 M
Debt To Equity
0.51 %
N/A
0.12 %
(0.18) %
N/A
N/A
N/A
1.55 %
Short Ratio
0.68 X
N/A
N/A
0.22 X
N/A
N/A
0.01 X
0.42 X
Target Price
0.5
N/A
N/A
10.0
N/A
N/A
0.5
10.0
Shares Owned By Institutions
23.50 %
7.95 %
N/A
11.60 %
N/A
N/A
2.77 %
83.13 %
Market Capitalization
2.67 M
65.67 M
1.17 M
13.24 M
8.29 K
23.22 K
3.86 M
7 M
Price To Earning
N/A
N/A
(0.15) X
(1.41) X
N/A
18.00 X
N/A
(4.19) X
Price To Earnings To Growth
N/A
N/A
N/A
(0.02) X
N/A
N/A
N/A
N/A
Price To Sales
0.73 X
88.51 X
0.27 X
7.33 X
N/A
0.02 X
0.35 X
N/A
Net Income
(11.92 M)
(3.76 M)
(658.02 K)
(30.37 M)
(133.17 K)
(2.66 M)
(15.55 M)
(114.53 M)
Earnings Per Share
(0.41) X
(0.30) X
(0.03) X
(1.15) X
N/A
N/A
(63.20) X
(15.64) X
Shares Owned By Insiders
3.15 %
22.68 %
N/A
31.53 %
N/A
N/A
23.37 %
0.23 %
Revenue
7.16 M
1.48 M
N/A
N/A
N/A
1.39 M
8.15 M
N/A
Working Capital
27.31 M
N/A
(1.58 M)
(25.27 M)
N/A
34 K
(5.37 M)
39.18 M
Cash And Equivalents
88.97 M
N/A
817.29 K
6.32 M
34.78 K
677.52 K
164.26 K
92.01 M
Cash Per Share
3.14 X
N/A
0.01 X
0.36 X
N/A
0.01 X
N/A
0.85 X
Gross Profit
(15.55 M)
(1.4 M)
(401.75 K)
(22.61 M)
(5.89 K)
(472 K)
8.57 M
N/A
Day Typical Price
0.0036
2.0E-4
1.0E-4
2.0E-4
1.0E-4
3.0E-4
0.0037
1.0E-4
Accumulation Distribution
0.26
N/A
N/A
N/A
N/A
N/A
0.41
N/A
Market Facilitation Index
0.001
N/A
N/A
N/A
N/A
N/A
0.0021
N/A
Daily Balance Of Power
0.9
0.0
0.0
(9,223,372,036,855)
0.0
0.0
0.4762
(9,223,372,036,855)
Period Momentum Indicator
9.0E-4
N/A
N/A
(0)
N/A
N/A
0.001
(0.0004)
Rate Of Daily Change
1.3
1.0
1.0
0.087
1.0
1.0
1.5
0.2
Day Median Price
0.0034
2.0E-4
1.0E-4
2.0E-4
1.0E-4
3.0E-4
0.0041
1.0E-4
Price Action Indicator
0.001
N/A
N/A
(0)
N/A
N/A
(0.0006)
(0.0002)
Coefficient Of Variation
570.06
N/A
N/A
282.94
N/A
N/A
421.96
1194.97
Mean Deviation
128.33
N/A
N/A
222.81
N/A
N/A
57.43
17.0
Jensen Alpha
65.01
N/A
N/A
112.76
N/A
N/A
20.62
3.95
Total Risk Alpha
28.6
N/A
N/A
82.31
N/A
N/A
12.34
(0.90)
Sortino Ratio
0.8569
N/A
N/A
1.33
N/A
N/A
0.3659
N/A
Downside Variance
5988.95
N/A
N/A
7472.1
N/A
N/A
3376.7
N/A
Standard Deviation
378.5
N/A
N/A
324.62
N/A
N/A
90.05
55.22
Kurtosis
50.31
N/A
N/A
3.16
N/A
N/A
8.57
42.18
Potential Upside
100.0
N/A
N/A
1000.0
N/A
N/A
233.33
N/A
Treynor Ratio
3.39
N/A
N/A
4.12
N/A
N/A
2.12
0.4897
Maximum Drawdown
990.0
N/A
N/A
1141.3
N/A
N/A
540.0
400.0
Variance
143263.96
N/A
N/A
105377.11
N/A
N/A
8109.84
3049.47
Market Risk Adjusted Performance
3.4
N/A
N/A
4.13
N/A
N/A
2.13
0.4997
Risk Adjusted Performance
0.1334
N/A
N/A
0.2587
N/A
N/A
0.1767
0.0688
Skewness
6.85
N/A
N/A
2.16
N/A
N/A
2.56
5.99
Semi Deviation
23.86
N/A
N/A
39.74
N/A
N/A
33.32
N/A
Information Ratio
0.1752
N/A
N/A
0.3532
N/A
N/A
0.2361
0.0822
Value At Risk
(70.00)
N/A
N/A
(90.91)
N/A
N/A
(72.73)
(50.00)
Expected Short fall
(479.83)
N/A
N/A
(614.88)
N/A
N/A
(114.39)
N/A
Downside Deviation
77.39
N/A
N/A
86.44
N/A
N/A
58.11
N/A
Semi Variance
569.25
N/A
N/A
1579.0
N/A
N/A
1110.16
N/A

Acutus Medical Competition Performance Charts

Five steps to successful analysis of Acutus Medical Competition

Acutus Medical's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Acutus Medical in relation to its competition. Acutus Medical's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Acutus Medical in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Acutus Medical's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Acutus Medical, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Acutus Medical position

In addition to having Acutus Medical in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Oil And Gas Thematic Idea Now

Oil And Gas
Oil And Gas Theme
Companies involved in drilling, production, and distribution of oil and gas pipelines. The Oil And Gas theme has 14 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Oil And Gas Theme or any other thematic opportunities.
View All  Next Launch

Other Information on Investing in Acutus Pink Sheet

Acutus Medical financial ratios help investors to determine whether Acutus Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Acutus with respect to the benefits of owning Acutus Medical security.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2025 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY